Theragnostic Imaging
Theragnostic Imaging
News
People
Events
Publications
RNTreg
Contact
Eivor Hernes
Latest
First-in-Human Phase 0 Study of AB001, a Prostate-Specific Membrane Antigen-Targeted (212)Pb Radioligand, in Patients with Metastatic Castration-Resistant Prostate Cancer.
Outcome Prediction Based on [18F]FDG PET/CT in Patients with Pleural Mesothelioma Treated with Ipilimumab and Nivolumab +/- UV1 Telomerase Vaccine.